Tigeciclina en infecciones de piel y tejidos blandos complicadas

Rodríguez, José Yesid; Valderrama, Sandra Liliana; Osorio-Pinzón, Johanna; Cataño, Juan Carlos; Cortés, Jorge Alberto; Mora, Leonardo Arévalo; Álvarez-Moreno, Arturo.
Infectio ; 21(4): 223-233, oct.-dic. 2017. tab
Artigo em Espanhol | LILACS, COLNAL | ID: biblio-892736

Documentos relacionados

  1. Tigeciclina en infecciones intraabdominales complicadas
  2. Impact of Tigecycline on C. difficile Outcomes: Case Series and Propensity-Matched Retrospective Study.
  3. Inhibition of mitochondrial function by approved drugs overcomes nasopharyngeal carcinoma chemoresistance.
  4. Dual-targeting tigecycline nanoparticles for treating intracranial infections caused by multidrug-resistant Acinetobacter baumannii.
  5. Efficacy and safety of tigecycline for Mycobacterium abscessus disease.
  6. The Assessment of Anti-Melanoma Potential of Tigecycline-Cellular and Molecular Studies of Cell Proliferation, Apoptosis and Autophagy on Amelanotic and Melanotic Melanoma Cells.
  7. Intra-abdominal infection after tumor surgery: tigecycline combined with ß-lactam antibiotics versus tigecycline alone.
  8. Tigecycline for the treatment of patients with Clostridium difficile infection: an update of the clinical evidence.
  9. Multiple heteroresistance to tigecycline and colistin in Acinetobacter baumannii isolates and its implications for combined antibiotic treatment.
  10. Colistin monotherapy or combination for the treatment of bloodstream infection caused by Klebsiella pneumoniae: a systematic review and meta-analysis.